IP21-08: Risk of death after aquablation and minimally invasive surgical treatment for LUTS/BPH: analysis of the Food and Drug Administration's Manufacturer and User Facility Device Experience Database
Friday, May 15, 2026 3:30 PM to 5:30 PM · 1 hr. 59 min. (America/New_York)
146B
Abstract